0.1876
24-January-25 15:45:00
15 minutes delayed
Stocks
+0.0013
+0.70%
Today's range
0.1844 - 0.1943
ISIN
N/A
Source
NASDAQ
Lyra Therapeutics Announces Positive Topline Results of Pharmacokinetic Study of LYR-210 in Patients with Chronic Rhinosinusitis
30 Jun 2021 06:00:00 By Nasdaq GlobeNewswire